PROCEPT BioRobotics Corporation
PRCT
PROCEPT BioRobotics Corporation, a surgical robotics company, develops transformative solutions in urology. It develops, manufactures, and sells AquaBeam Robotic System, an image-guided, surgical robotic system for use in minimally-invasive urologic surgery with a focus on treating benign prostatic hyperplasia (BPH). The company also designs Aquablation therapy for males suffering from lower urinaā¦ read more
Healthcare
Medical Devices
4 years
USD
Exclusive to Premium users
Price
per share adjusted in USD$30.98
Price-1.53%
-$0.48
1Y
Price
Market Cap
$1.731b
Small
Price/Earnings 3y Avg5y Avg
-
Premium
Premium
Financial Reports
Key metrics over the past few years and other important metrics. Amounts in USD.-23.7%
EBITDA Margin-25.7%
Net Profit Margin-11.4%
Free Cash Flow Margin-23.7%
EBITDA Margin-25.7%
Net Profit Margin-11.4%
Free Cash Flow MarginRevenue
$299.907m
+33.6%
1y CAGR+60.0%
3y CAGR+74.4%
5y CAGREarnings
-$84.582m
+7.5%
1y CAGR-0.1%
3y CAGR-11.5%
5y CAGREPS
-$1.53
+12.6%
1y CAGR+6.7%
3y CAGR+16.5%
5y CAGRBook Value
$380.276m
$511.541m
Assets$131.265m
Liabilities$78.926m
DebtDebt to Assets
15.4%
-1x
Debt to EBITDAFree Cash Flow
-$79.729m
+23.1%
1y CAGR-5.0%
3y CAGR-14.6%
5y CAGRNo items found.
Press Releases
Statements and updates from the company